FDA panel narrowly backs unapproved peptide drugs favoured by RFK Jr and wellness influencers
If FDA follows that advice, telehealth companies are expected to ramp up marketing of the chemicals for wellness and cosmetic uses.Thursday's vote tally reflected the unusual makeup of the panel. The FDA isn't required to follow the group's advice, though it usually does.FDA scientists remain unconvinced of peptide safety and benefits. “There aren't that many other substances people are injecting into themselves where you see that the clinical evidence is so lacking.” In recent years, the FDA has warned Americans about the risks of injecting peptides like BPC-157 and TB-500.
- ▪If FDA follows that advice, telehealth companies are expected to ramp up marketing of the chemicals for wellness and cosmetic uses.Thursday's vote tally reflected the unusual makeup of the panel.
- ▪The FDA isn't required to follow the group's advice, though it usually does.FDA scientists remain unconvinced of peptide safety and benefits.
- ▪“There aren't that many other substances people are injecting into themselves where you see that the clinical evidence is so lacking.” In recent years, the FDA has warned Americans about the risks of injecting peptides like BPC-157 and TB-5
The Hindu publishes from India and files mainly under world. We currently carry 626 of its stories.
Opening excerpt (first ~120 words) tap to expand
A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals haven't been shown safe or effective.In a series of votes, outside experts to the Food and Drug Administration advised the agency to drop current restrictions barring pharmacies from producing injectable peptides with names like BPC-157, TB-500 and KPV.The panel's vote is not binding but is likely to embolden Health Secretary Robert F Kennedy Jr., who has described himself as a “big fan” of peptides and vowed to overturn FDA restrictions put in place under President Joe Biden.Across several votes, the panelists voted 8-6, with one abstention, in favour of putting the peptides…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hindu.
Discussion
0 commentsMore from The Hindu
